Under construction – not a live service
Sign in
Taking people in GermanyNo phase

Studies how metabolism changes in people after a heart transplant

Follows heart transplant recipients over time to observe their heart and body metabolism.

Plain-language title generated from the registry record
Registry title: METABolic Deterioration in HTX Determines Outcomes

Key facts

Where
Düsseldorf, GermanySee the site

Where in Germany

  • University-Hospital Düsseldorf Division of Cardiology, Pneumology and AngiologyDüsseldorf, GermanyTaking people

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?
Print a page for my doctor

Trial details

Who runs it
Heinrich-Heine University, Duesseldorf
Trial code
NCT07372820
Record updated
28 January 2026
Original description
METAB-HTX is a prospective, longitudinal cohort study evaluating cardiac and systemic metabolism in heart transplant recipients.Read full original descriptionShow less

METAB-HTX: Prospective, Longitudinal Cohort Study Evaluationg Cardiac and Systemic Metabolism After Heart Transplantation

METAB-HTX is a prospective, longitudinal cohort study evaluating cardiac and systemic metabolism in heart transplant recipients.

Inclusion: Age: ≥ 18 years; Planned or already conducted heart transplantation; Informed consent.

Exclusion: Absence of informed consent.

ClinicalTrials.gov NCT07372820